Drug shortages are a persistent public health issue in the US. There is no easy method to scale up production to meet periodic sharp increases in demand, like the one occurring at the moment as a result of the "tripledemic." And there is a limited profit motive to do so, particularly for generics.
Subscribe to:
Post Comments (Atom)
< + > Bonus Features, HIMSS Edition – March 11, 2026 – Epic AI news, Microsoft Dragon Copilot integrations, plus 22 other stories
Welcome to a special edition of Healthcare IT Today Bonus Features including interesting stories, product announcements, new hires, partner...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Solution Erases Long Phone Holds for Patients, Supports Overwhelmed Medical Front Desk Workers, and Improves Patient Access to Physicians A...
-
Announcement written by Zack Kanter, Founder and CEO at Stedi In February of last year, I gathered our engineering team in a war room. Chan...
No comments:
Post a Comment